Sep. 15 at 2:17 PM
$ABOS CITI Summit 2026 September 10:
we are rapidly approaching the conclusion of the study. So we're very excited.
Geoffrey Meacham
Citigroup Inc., Research Division
And let me ask you, too, on the -- you're going to give the full details? Or is this going to be like wait till CTAD...
Daniel O'Connell
CEO & Director
Yes, yes. We don't have the luxury of waiting. So -- and we've been waiting for these data for a long time. So I shouldn't -- we will be disclosing in a fulsome way that, again, is interpretable and actionable in the moment, not kind of previewing something and holding for a future conference. So yes, no, that's our commitment to all the stakeholders, participants in the study, investigators, investors, and others.
Tomorrow investor day is going to be very bullish expectation of ALTITUDE-AD presentation, IMO.
https://seekingalpha.com/article/4945146-acumen-pharmaceuticals-inc-abos-presents-at-citigroups-biopharma-back-to-school-summit-2026
